Agriculture is undergoing a fundamental repricing of risk rather than a temporary downcycle, forcing a structural shift where defending legacy assets is becoming riskier than active reinvention. As the industry faces “pharma-ization”—characterized by rising regulatory costs and a pivot from internal R&D to external innovation sourcing—value is migrating away from traditional vertical integration toward strategic “choke points” like formulation, aggregated IP, and distribution channels. This pressure is driving a wave of survival-based consolidation and a retreat of short-term venture capital, clearing the way for long-horizon “orchestrators” capable of aligning capital, biology, and data to manage volatility. Ultimately, the sector is resetting its cost of capital and operating models, rewarding those who can transition from simple scale to complex system management and verifiable outcomes.
Source: Guest article: Agriculture’s great repricing goes beyond the downcycle